In his inaugural J.P. Morgan Healthcare Conference speech, newly minted Dexcom CEO Jake Leach looked to ease concerns over ...
DexCom, Inc. DXCM reported strong preliminary results for the fourth quarter and full-year 2025. Despite the robust preliminary results, the company’s shares have lost nearly 2.5% since the ...
While still a couple of years out, MD+DI gained some insights into Dexcom's next-generation sensor from an interview with the ...
DexCom, Inc. (NASDAQ:DXCM) is one of the Best Fundamental Stocks to Buy According to Analysts. On January 12, the company ...
Medical Device Network on MSN
JPM26: Dexcom’s new CEO eyes international CGM markets for 2026 growth
Dexcom’s new CEO is eyeing growth in the international market as a key strategy for 2026, fresh off the back of the company ...
Zacks Investment Research on MSN
Here's why you should hold DexCom stock in your portfolio for now
DexCom, Inc. DXCM is well positioned for growth in the coming quarters, supported by the significant potential of the ...
Roxy Horner cut a chic figure as she arrived at swanky restaurant Sale E Pepe in Knightsbridge, London, on Saturday for ...
Some of medtech's most innovative technologies were on display at the Consumer Electronics Show (CES) in Las Vegas this week.
In July, Leach was tapped to take the CEO role permanently at the start of 2026 as part of Dexcom’s planned succession ...
Diabeloop receives US FDA 510(k) clearance for DBLG2, an automated insulin delivery algorithm: Grenoble, France Saturday, January 10, 2026, 10:00 Hrs [IST] Diabeloop, a global com ...
Dexcom (NSDQ:DXCM) today announced preliminary fourth-quarter results that included revenues that topped the consensus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback